Gen Surg Cases · vascular
Aortoiliac claudicant with a diabetic foot ulcer in the family — exercise prescription, revascularisation restraint, and arterial assessment of every ulcer
Fellowship clinical-management station on aortoiliac claudication: Cochrane and CLEVER exercise prescribing with ERASE long-term restraint, cilostazol honesty, and diabetic-foot PAD assessment by IWGDF structure.
On this page
Study tools
Target exams
Candidate tasks and model management
Prescribe the claudicant's exercise plan with numbers, not adjectives. Supervised exercise first: Cochrane pooling gives pain-free distance up 82.11 m and maximum distance up 120.36 m across 32 trials with 1835 participants, high-quality evidence, with benefits to two years and no ABI, mortality or amputation signal.[16] Set expectations with CLEVER: at 18 months peak walking gains run 5.0 minutes with exercise and 3.2 with stenting against 0.2 with medical care alone, exercise versus stenting statistically tied.[14] Add smoking-cessation, diet, exercise and foot-care counselling plus best medical therapy classes per GVG, and address his smoking directly — current smoking carries the highest PAD meta-odds at 2.72 in high-income settings.[1]
Justify procedural restraint — and name when stenting earns its place. Decline first-line stenting: ERASE long-term follow-up shows the 1-year combination walking advantage fading to a nonsignificant 53 m at 5.4 years, with lifetime procedure totals of 65 versus 149 favouring exercise-only despite a 2.50-fold hazard of later revascularisation in the exercise-only arm.[15] Reserve stenting for durable disease-specific quality-of-life gains in aortoiliac disease per CLEVER, or for progression toward CLTI — claudication itself is a function problem, not a threat problem.[14] Offer cilostazol only with full modesty: initial distance up 26.49 m and absolute up 39.57 m with headache odds of 2.83 and no hard-outcome verdict.[17]
Assess the sister's ulcer as a PAD case first. Approximately half of diabetic foot ulcers carry PAD with raised limb and cardiovascular risk, so absent pulses make hers an arterial case until proven otherwise — not a dressing-clinic case.[19] Work the IWGDF structure: five recommendations for diagnosis with and without ulcer or gangrene, five for prognosis of healing and amputation, fifteen for treatment covering prioritisation, procedure choice and post-surgical care.[19] If CLTI criteria are met (ulcer beyond 2 weeks on a PAD leg), refer urgently to vascular surgery, stage by WIfI with toe pressures, decide by PLAN and conduit, and set long-term limb surveillance after any revascularisation.[4]
References7ShowHide
- [1]Fowkes FG, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet, 2013.PMID 23915883
- [16]Lane R, et al. Exercise for intermittent claudication. Cochrane Database Syst Rev, 2017.PMID 29278423
- [14]Murphy TP, et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. J Am Coll Cardiol, 2015.PMID 25766947
- [15]Klaphake S, et al. Long-term Follow-up of a Randomized Clinical Trial Comparing Endovascular Revascularization Plus Supervised Exercise With Supervised Exercise Only for Intermittent Claudication. Ann Surg, 2022.PMID 33378308
- [17]Brown T, et al. Cilostazol for intermittent claudication. Cochrane Database Syst Rev, 2021.PMID 34192807
- [19]Fitridge R, et al. The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes mellitus and a foot ulcer. J Vasc Surg, 2023.PMID 37724985
- [4]Conte MS, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg, 2019.PMID 31159978